E

Everest Medicines
1952

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$16.38B
EV
HK$15.29B
Shares Outstanding
336.16M
Beta
1.60

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
HK$47.92
P/E 2025E
-
P/Revenue 2025E
10.23x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Everest Medicines Limited

gainify

E

Everest Medicines Limited

1952

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline includes Nefeco...

Sector

Healthcare

Industry

Biotechnology

CEO

Luo, Yongqing

Employees

665

IPO Date

2020-10-09

Headquarters

CITIC Pacific Plaza, 16th Floor, 1168 West Nanjing Road, Jing’an District, Shanghai 200041, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.